Follow The Filings

ABSI Absci Corporation

Health Care, filed as Absci Corp (COMMON STOCK), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 1.0%
  • $150M
  • 1 reduce

In 2026 Q2 Cathie Wood trimmed Absci.

Who owns this now

Largest portfolio weights among holders, up to 1.0% (Cathie Wood, Ark Investment Management). Not free-float ownership.

  1. Cathie Wood Reduce 0.97%

Who owns ABSI

Sorted by value, long equity only, as of 2026 Q2.

History
Cathie Wood, Ark Investment Management 0.97% Reduce −5.8% 12,925,271 $150M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ABSI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ABSI insider trades
  • $933K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Mary T Szela Director
    Buy
    $149K 12,900 shares at $11.54 +154% to stake
    Traded Jun 30 Filed Jul 6
    ↗
  2. Menelas N Pangalos Director
    Buy
    $201K 37,453 shares at $5.36 +19% to stake
    Traded May 13 Filed May 13
    ↗
  3. Andreas Busch Chief Innovation Officer
    Buy
    $229K 100,000 shares at $2.29 +31% to stake
    Traded Mar 12 Filed Mar 16
    ↗
  4. Menelas N Pangalos Director
    Buy
    $206K 75,095 shares at $2.74 +66% to stake
    Traded Feb 27 Filed Mar 3
    ↗
  5. Frans Van Houten Director
    Buy
    $149K 40,000 shares at $3.72 +172% to stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 share withholdings for taxes, 12 stock grants, 2 sales to cover taxes, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-K Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $5.72M $4.53M $2.8M
Net income -$110.57M -$103.11M -$115.18M
Net margin * -1933.6% -2274.1% -4113.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $120.58M $133.83M $149.57M
Total non-current assets * $96.72M $79.78M $66.72M
Total assets $217.3M $213.61M $216.3M
Total current liabilities $29.56M $28.66M $22.76M
Total non-current liabilities * $11.56M $5.82M $4.08M
Total equity $176.18M $179.13M $189.45M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$64.64M -$72.4M -$92.92M
Cash from investing $81.94M -$41.58M -$50.16M
Cash from financing -$4.48M $82.53M $105.95M
Net change in cash $12.82M -$31.45M -$37.14M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf